Analyst Ratings for Cue Biopharma (CUE) [Neutrals]

CUE Rating Summary

CUE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CUE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $30.00 (+127.4%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details